Delivery Order SPE2DB20D3103-SPE2DB25FN3H9

Award Date 4/7/25
Potential Completion Date 4/8/25
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,028.13, is for the delivery of TALTZ 80 MG/ML AUTOINJECTOR medical supply items. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an Ultimate Completion Date of March 6, 2024. This contract award is part of a larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,564.72 firm-fixed-price delivery order is for the supply of TALTZ 80 MG/ML AUTOINJECTORML, a pharmaceutical product. The contract has an ultimate completion date of November 1, 2024 and was awarded on October 31, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) worth $999,999,999 that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TALTZ 80 MG/ML AUTOINJECTORML, a pharmaceutical product, with a ceiling value of $157,254.66 and a period of performance through March 13, 2025. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,792.85 firm fixed-price delivery order is for the supply of TALTZ 80 MG/ML AUTOINJECTORML, with a completion date of February 18, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,688.79 contract is for the supply of TALTZ 80 MG/ML AUTOINJECTORML, a specialty pharmaceutical product. The delivery order contract has a firm fixed price pricing type and runs through October 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,497.04 firm fixed-price delivery order is for the supply of Taltz 80 mg/mL autoinjectors, a specialty medication. The contract has an ultimate completion date of October 30, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,649.13, is for the delivery of Taltz 80 mg/mL autoinjector medication. It is a firm fixed-price delivery order contract with an ultimate completion date of April 8, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,037.80, is a delivery order for the supply of TALTZ 80 MG/ML AUTOINJ (3-PK)ML, a pharmaceutical product. The contract has an ultimate completion date of October 30, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $51,874.91 firm fixed-price delivery order is for the supply of TALTZ 80 MG/ML AUTOINJECTORML, a medication, with an ultimate completion date of May 13, 2025. The contract is not designated as a set-aside and represents an open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $41,508.95 firm fixed-price delivery order is for the supply of TALTZ 80 MG/ML AUTOINJECTORML, a prescription medication. The contract has an ultimate completion date of March 3, 2025 and does not contain any set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FN3H9
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,700.44, is for the procurement of TALTZ 80 MG/ML AUTOINJECTORML, a pharmaceutical product. This is a Delivery Order contract with a Firm Fixed Price pricing type, and the ultimate completion date is April 8, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

This contract award does not have a set-aside designation, indicating open competition.

Generated 7/7/25, 1:11 PM